The SUDEP cohort has approximately threefold enrichment for loss‐of‐function KCNH2 variants (OR = 2.7, 95% confidence interval (1.1, 7.4), Fisher’s exact test nominal p = 0.04) compared with the epilepsy control population (Fig. 4A). The gene discussed is KCNH2; the disease is epilepsy.